Emergence Agitation Between Dexmedetomidine and Sevoflurane Anesthesia
Key facts
- Who runs it
- Pelita Harapan University
- Where
- Indonesia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 121 people enrolled
- Started
- 31 Jul 2024
- Ended
- 31 Dec 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Dexmedetomidine
- Sevoflurane
- Record updated
- 28 May 2025
Who can take part
- Age
- 3 months to 10 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients with weight ranging 5 kg - 25 kg
- Patients with American Society of Anesthesiologist (ASA) Physical Status Classification 1 and 2
Who cannot take part
- Patients with any acquired congenital syndrome
- Patients who are actively taking anti-seizure medications and/or has been diagnosed with epilepsy
- Patients with functional and structural abnormalities of the heart, including arrythmias
- Patients with liver disease
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Emergence agitation is commonly encountered after receiving inhalation anesthesia. This distressing phenomenon carries risks that are harmful to patients, caregivers and medical personnel. Using total intravenous Dexmedetomidine, the investigators seek to reduce agitation and provide gentle emergence from anesthesia.
The 2 groups in the trial
- Inhalation SevofluraneExisting treatment, for comparison
Participants in this group will receive inhalation anesthesia Sevoflurane at 2-3 Vol% as their sole anesthetic maintenance agent throughout the surgical procedure.
Treatment: Sevoflurane
- Total Intravenous DexmedetomidineTreatment being tested
Participants in this group will receive Total Intravenous Dexmedetomidine as their sole anesthetic maintenance agent. Intravenous Dexmedetomidine 1.5ug/kg will be administered within 10 minutes and maintenance dose of 1.5ug/kg/hour will be given throughout the surgical procedure.
Treatment: Dexmedetomidine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Emergence Agitation in Pediatrics After Dexmedetomidine vs. Sevoflurane Anesthesia: a Randomized Controlled Trial
- Record updated
- 28 May 2025